Extended haplotypes in the complement factor H (CFH) and CFH-related (CFHR) family of genes protect against

Gregory S Hageman1, Lisa S Hancox, Andrew J Taiber

  • 1Department of Ophthalmology and Visual Sciences, Cell Biology and Functional Genomics Laboratory, The University of Iowa, 11190E PFP, 200 Hawkins Drive, Iowa City, Iowa 52240, USA. gregory-hageman@uiowa.edu

Annals of Medicine
|April 19, 2007
PubMed

Insights

A common deletion of complement factor H-related genes 1 and 3 (CFHR1/CFHR3) is linked to age-related macular degeneration (AMD). This finding sheds light on the genetic underpinnings of AMD and the role of complement genes in immunity.

Area of Science:

  • Genetics
  • Immunology
  • Ophthalmology

Background:

  • Complement factor H gene (CFH) variants are implicated in age-related macular degeneration (AMD).
  • The CFH gene and five related genes (CFHR1-5) are located in the regulators of complement activation (RCA) locus on chromosome 1q32.
  • Understanding the interplay between these genes and AMD is crucial.

Purpose of the Study:

  • To refine the understanding of structural and evolutionary relationships between CFH, CFHR genes, and AMD.
  • To investigate the impact of genetic variations within the RCA locus on AMD susceptibility.

Main Methods:

  • Employed a combined genetic, molecular, and immunohistochemical approach.
  • Identified and characterized a large deletion encompassing CFHR1 and CFHR3 genes.
  • Conducted genotyping analyses of AMD cases and controls from two independent cohorts.

Main Results:

  • A common deletion removing CFHR1 and CFHR3 was identified; individuals homozygous for this deletion lack CFHR1 protein.
  • Deletion homozygotes were found in 1.1% of AMD cases and 5.7% of controls, indicating a significant association (P=1.6 E-09).
  • CFHR1 and CFHR3 transcripts were abundant in the liver but not detected in the ocular retinal pigmented epithelium/choroid complex.

Conclusions:

  • The absence of CFHR1 and/or CFHR3 may explain the protective effects of certain CFH haplotypes.
  • High frequencies of the 402H allele and delCFHR1/CFHR3 alleles in African populations suggest ancient origins.
  • Genetic diversity at the RCA locus, potentially driven by selection, highlights the role of CFHR genes in innate immunity.
Abstract

Related Concept Videos

Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
Genetic Lingo01:11

Genetic Lingo

Overview
Exon Recombination02:32

Exon Recombination

The evolution of new genes is critical for speciation. Exon recombination, also known as exon shuffling or domain shuffling, is an important means of new gene formation. It is observed across vertebrates, invertebrates, and in some plants such as potatoes and sunflowers. During exon recombination, exons from the same or different genes recombine and produce new exon-intron combinations, which might evolve into new genes. 
Exon shuffling follows “splice frame rules.” Each exon has three reading...
Human Genetics01:28

Human Genetics

Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu01:29

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
Principles of Pharmacogenetics: Types of Genetic Variants01:27

Principles of Pharmacogenetics: Types of Genetic Variants

The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...